BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sun Y. Tumor microenvironment and cancer therapy resistance. Cancer Lett 2016;380:205-15. [PMID: 26272180 DOI: 10.1016/j.canlet.2015.07.044] [Cited by in Crossref: 142] [Cited by in F6Publishing: 166] [Article Influence: 20.3] [Reference Citation Analysis]
Number Citing Articles
1 Wu P, Han J, Gong Y, Liu C, Yu H, Xie N. Nanoparticle-Based Drug Delivery Systems Targeting Tumor Microenvironment for Cancer Immunotherapy Resistance: Current Advances and Applications. Pharmaceutics 2022;14:1990. [DOI: 10.3390/pharmaceutics14101990] [Reference Citation Analysis]
2 Mendes R, Graça G, Silva F, Guerreiro ACL, Gomes-alves P, Serpa J, Boghaert ER, Alves PM, Félix A, Brito C, Isidro IA. Exploring Metabolic Signatures of Ex Vivo Tumor Tissue Cultures for Prediction of Chemosensitivity in Ovarian Cancer. Cancers 2022;14:4460. [DOI: 10.3390/cancers14184460] [Reference Citation Analysis]
3 Dong Z, Wang C, Gong Y, Zhang Y, Fan Q, Hao Y, Li Q, Wu Y, Zhong X, Yang K, Feng L, Liu Z. Chemical Modulation of Glucose Metabolism with a Fluorinated CaCO3 Nanoregulator Can Potentiate Radiotherapy by Programming Antitumor Immunity. ACS Nano 2022. [PMID: 36075132 DOI: 10.1021/acsnano.2c02688] [Reference Citation Analysis]
4 Liu J, Shen H, Chen X, Ding Y, Wang H, Xu N, Teng L. Expression and Prognostic Value of Chromobox Family Proteins in Esophageal Cancer. Genes (Basel) 2022;13:1582. [PMID: 36140750 DOI: 10.3390/genes13091582] [Reference Citation Analysis]
5 Liu Y, Li X, Zhu L, Zhao Z, Wang T, Zhang X, Cai B, Li L, Ma M, Ma X, Ming J, Hashmi MF. Preoperative Prediction of Axillary Lymph Node Metastasis in Breast Cancer Based on Intratumoral and Peritumoral DCE-MRI Radiomics Nomogram. Contrast Media & Molecular Imaging 2022;2022:1-10. [DOI: 10.1155/2022/6729473] [Reference Citation Analysis]
6 Tsolou A, Koparanis D, Lamprou I, Giatromanolaki A, Koukourakis MI. Increased glucose influx and glycogenesis in lung cancer cells surviving after irradiation. Int J Radiat Biol 2022;:1-15. [PMID: 35976051 DOI: 10.1080/09553002.2022.2113837] [Reference Citation Analysis]
7 Li D, Li X, Zhao J, Tan F. Advances in nuclear medicine-based molecular imaging in head and neck squamous cell carcinoma. J Transl Med 2022;20:358. [PMID: 35962347 DOI: 10.1186/s12967-022-03559-5] [Reference Citation Analysis]
8 Lin H, Wang Y, Wang P, Long F, Wang T. Mutual regulation between N6-methyladenosine (m6A) modification and circular RNAs in cancer: impacts on therapeutic resistance. Mol Cancer 2022;21:148. [PMID: 35843942 DOI: 10.1186/s12943-022-01620-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Biscaia SMP, Pires C, Lívero FAR, Bellan DL, Bini I, Bustos SO, Vasconcelos RO, Acco A, Iacomini M, Carbonero ER, Amstalden MK, Kubata FR, Cummings RD, Dias-baruffi M, Simas FF, Oliveira CC, Freitas RA, Franco CRC, Chammas R, Trindade ES. MG-Pe: A Novel Galectin-3 Ligand with Antimelanoma Properties and Adjuvant Effects to Dacarbazine. IJMS 2022;23:7635. [DOI: 10.3390/ijms23147635] [Reference Citation Analysis]
10 Kutoka PT, Seidu TA, Baye V, Khamis AM, Omonova CTQ, Wang B. Current nano-strategies to target tumor microenvironment (TME) to improve anti-tumor efficiency. OpenNano 2022;7:100041. [DOI: 10.1016/j.onano.2022.100041] [Reference Citation Analysis]
11 Choi BH, Ryoo I, Sim KH, Ahn HJ, Lee YJ, Kwak MK. High Levels of Hyaluronic Acid Synthase-2 Mediate NRF2-Driven Chemoresistance in Breast Cancer Cells. Biomol Ther (Seoul) 2022;30:368-79. [PMID: 35768333 DOI: 10.4062/biomolther.2022.074] [Reference Citation Analysis]
12 Janssen JBE, Medema JP, Gootjes EC, Tauriello DVF, Verheul HMW. Mutant RAS and the tumor microenvironment as dual therapeutic targets for advanced colorectal cancer. Cancer Treat Rev 2022;109:102433. [PMID: 35905558 DOI: 10.1016/j.ctrv.2022.102433] [Reference Citation Analysis]
13 Simón L, Sanhueza S, Gaete-Ramírez B, Varas-Godoy M, Quest AFG. Role of the Pro-Inflammatory Tumor Microenvironment in Extracellular Vesicle-Mediated Transfer of Therapy Resistance. Front Oncol 2022;12:897205. [PMID: 35646668 DOI: 10.3389/fonc.2022.897205] [Reference Citation Analysis]
14 Su X, Xue C, Xie C, Si X, Xu J, Huang W, Huang Z, Lin J, Chen Z. lncRNA-LET Regulates Glycolysis and Glutamine Decomposition of Esophageal Squamous Cell Carcinoma Through miR-93-5p/miR-106b-5p/SOCS4. Front Oncol 2022;12:897751. [PMID: 35619921 DOI: 10.3389/fonc.2022.897751] [Reference Citation Analysis]
15 Xue L, Gong N, Shepherd SJ, Xiong X, Liao X, Han X, Zhao G, Song C, Huang X, Zhang H, Padilla MS, Qin J, Shi Y, Alameh MG, Pochan DJ, Wang K, Long F, Weissman D, Mitchell MJ. Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment. J Am Chem Soc 2022. [PMID: 35616998 DOI: 10.1021/jacs.2c02706] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
16 Zhu L, Meng D, Wang X, Chen X. Ferroptosis-Driven Nanotherapeutics to Reverse Drug Resistance in Tumor Microenvironment. ACS Appl Bio Mater 2022. [PMID: 35614872 DOI: 10.1021/acsabm.2c00199] [Reference Citation Analysis]
17 Bukhari SNA. Emerging Nanotherapeutic Approaches to Overcome Drug Resistance in Cancers with Update on Clinical Trials. Pharmaceutics 2022;14:866. [PMID: 35456698 DOI: 10.3390/pharmaceutics14040866] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Yu X, Xu J, Xu D, Bi X, Wang H, Lu Y, Cao M, Wang W, Xu Z, Zheng D, Chen L, Zhang X, Zheng S, Li K. Comprehensive Analysis of the Carcinogenic Process, Tumor Microenvironment, and Drug Response in HPV-Positive Cancers. Front Oncol 2022;12:842060. [PMID: 35392231 DOI: 10.3389/fonc.2022.842060] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Shin DS, Schroeder ME, Anseth KS. Impact of Collagen Triple Helix Structure on Melanoma Cell Invadopodia Formation and Matrix Degradation upon BRAF Inhibitor Treatment. Adv Healthc Mater 2022;11:e2101592. [PMID: 34783464 DOI: 10.1002/adhm.202101592] [Reference Citation Analysis]
20 Liu XY, Zhang Q, Guo J, Zhang P, Liu H, Tian ZB, Zhang CP, Li XY. The Role of Circular RNAs in the Drug Resistance of Cancers. Front Oncol 2021;11:790589. [PMID: 35070998 DOI: 10.3389/fonc.2021.790589] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Michon S, Rodier F, Yu FTH. Targeted Anti-Cancer Provascular Therapy Using Ultrasound, Microbubbles, and Nitrite to Increase Radiotherapy Efficacy. Bioconjug Chem 2022. [PMID: 34990112 DOI: 10.1021/acs.bioconjchem.1c00510] [Reference Citation Analysis]
22 Vachenc S, Gobbo J, Moujarrebe SE, Desmoulins I, Gilabert M, Beau-Faller M, Mitry E, Girard N, Bertaut A, Dusetti N, Iovanna JL, Yousfi R, Pierrat F, Bruno R, Cueff A, Boidot R, Genne P. OncoSNIPE® Study Protocol, a study of molecular profiles associated with development of resistance in solid cancer patients. BMC Cancer 2022;22:41. [PMID: 34991520 DOI: 10.1186/s12885-021-09134-3] [Reference Citation Analysis]
23 Li J, Gong S, Li S, Li X, Lan S, Sun M. Tumor-penetrating iron oxide nanoclusters for T1 / T2 dual mode MR imaging-guided combination therapy. Biomater Sci . [DOI: 10.1039/d2bm00667g] [Reference Citation Analysis]
24 Dabbour NM, Salama AM, Donia T, Al-deeb RT, Abd Elghane AM, Badry KH, Loutfy SA. Managing GSH elevation and hypoxia to overcome resistance of cancer therapies using functionalized nanocarriers. Journal of Drug Delivery Science and Technology 2022;67:103022. [DOI: 10.1016/j.jddst.2021.103022] [Reference Citation Analysis]
25 Damalanka VC, Voss JJLP, Mahoney MW, Primeau T, Li S, Klampfer L, Janetka JW. Macrocyclic Inhibitors of HGF-Activating Serine Proteases Overcome Resistance to Receptor Tyrosine Kinase Inhibitors and Block Lung Cancer Progression. J Med Chem 2021;64:18158-74. [PMID: 34902246 DOI: 10.1021/acs.jmedchem.1c01671] [Reference Citation Analysis]
26 Wang Z, Liu Y, Zhang J, Zhao R, Zhou X, Wang H. An Immune-Related Long Noncoding RNA Signature as a Prognostic Biomarker for Human Endometrial Cancer. J Oncol 2021;2021:9972454. [PMID: 34925511 DOI: 10.1155/2021/9972454] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
27 Wen J, Luo Y, Gao H, Zhang L, Wang X, Huang J, Shang T, Zhou D, Wang D, Wang Z, Li P, Wang Z. Mitochondria-targeted nanoplatforms for enhanced photodynamic therapy against hypoxia tumor. J Nanobiotechnology 2021;19:440. [PMID: 34930284 DOI: 10.1186/s12951-021-01196-6] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
28 Law AMK, Rodriguez de la Fuente L, Grundy TJ, Fang G, Valdes-Mora F, Gallego-Ortega D. Advancements in 3D Cell Culture Systems for Personalizing Anti-Cancer Therapies. Front Oncol 2021;11:782766. [PMID: 34917509 DOI: 10.3389/fonc.2021.782766] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
29 Guan XY, Guan XL, Jiao ZY. Improving therapeutic resistance: beginning with targeting the tumor microenvironment. J Chemother 2021;:1-25. [PMID: 34873999 DOI: 10.1080/1120009X.2021.2011661] [Reference Citation Analysis]
30 Zhu PF, Wang MX, Chen ZL, Yang L. Targeting the Tumor Microenvironment: A Literature Review of the Novel Anti-Tumor Mechanism of Statins. Front Oncol 2021;11:761107. [PMID: 34858839 DOI: 10.3389/fonc.2021.761107] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
31 Chroni A, Kumar S. Tumors Are Evolutionary Island-Like Ecosystems. Genome Biol Evol 2021;13:evab276. [PMID: 34894238 DOI: 10.1093/gbe/evab276] [Reference Citation Analysis]
32 Liu H, Zhao H, Sun Y. Tumor microenvironment and cellular senescence: Understanding therapeutic resistance and harnessing strategies. Semin Cancer Biol 2021:S1044-579X(21)00271-6. [PMID: 34799201 DOI: 10.1016/j.semcancer.2021.11.004] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
33 Seebacher NA, Krchniakova M, Stacy AE, Skoda J, Jansson PJ. Tumour Microenvironment Stress Promotes the Development of Drug Resistance. Antioxidants (Basel) 2021;10:1801. [PMID: 34829672 DOI: 10.3390/antiox10111801] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
34 Rasouli M, Fallah N, Bekeschus S. Combining Nanotechnology and Gas Plasma as an Emerging Platform for Cancer Therapy: Mechanism and Therapeutic Implication. Oxid Med Cell Longev 2021;2021:2990326. [PMID: 34745414 DOI: 10.1155/2021/2990326] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
35 Brulin B, Nolan JC, Marangon T, Kovacevic M, Chatelais M, Meheust P, Abadie J, Le Nail LR, Rosset P, Brennan MÁ, Layrolle P. Evaluation of the Chemotherapy Drug Response Using Organotypic Cultures of Osteosarcoma Tumours from Mice Models and Canine Patients. Cancers (Basel) 2021;13:4890. [PMID: 34638373 DOI: 10.3390/cancers13194890] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Mardomi A, Ghollasi M, Korani M, Panahi M, Parsa-Kondelaji M, Sabzichi M, Salimi A. Blockade of TGF-βR improves the efficacy of doxorubicin by modulating the tumor cell motility and affecting the immune cells in a melanoma model. Naunyn Schmiedebergs Arch Pharmacol 2021;394:2309-22. [PMID: 34499199 DOI: 10.1007/s00210-021-02134-x] [Reference Citation Analysis]
37 Deshmukh SK, Srivastava SK, Zubair H, Khan MA, Singh AP, Singh S. Resistin Induces LIN28A-Mediated Let-7a Repression in Breast Cancer Cells Leading to IL-6 and STAT3 Upregulation. Cancers (Basel) 2021;13:4498. [PMID: 34572725 DOI: 10.3390/cancers13184498] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
38 Kong R, Wang N, Han W, Bao W, Lu J. IFNγ-mediated repression of system xc- drives vulnerability to induced ferroptosis in hepatocellular carcinoma cells. J Leukoc Biol 2021;110:301-14. [PMID: 34318944 DOI: 10.1002/JLB.3MA1220-815RRR] [Cited by in F6Publishing: 14] [Reference Citation Analysis]
39 Picoli CC, Gonçalves BÔP, Santos GSP, Rocha BGS, Costa AC, Resende RR, Birbrair A. Pericytes cross-talks within the tumor microenvironment. Biochim Biophys Acta Rev Cancer 2021;:188608. [PMID: 34384850 DOI: 10.1016/j.bbcan.2021.188608] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
40 Cheng X, Gao J, Ding Y, Lu Y, Wei Q, Cui D, Fan J, Li X, Zhu E, Lu Y, Wu Q, Li L, Huang W. Multi-Functional Liposome: A Powerful Theranostic Nano-Platform Enhancing Photodynamic Therapy. Adv Sci (Weinh) 2021;8:e2100876. [PMID: 34085415 DOI: 10.1002/advs.202100876] [Cited by in Crossref: 13] [Cited by in F6Publishing: 19] [Article Influence: 13.0] [Reference Citation Analysis]
41 Too NSH, Ho NCW, Adine C, Iyer NG, Fong ELS. Hot or cold: Bioengineering immune contextures into in vitro patient-derived tumor models. Adv Drug Deliv Rev 2021;175:113791. [PMID: 33965462 DOI: 10.1016/j.addr.2021.05.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
42 Cheng T, Zhang J, Liu D, Lai G, Wen X. Prognosis of Non-small-cell Lung Cancer Patients With Lipid Metabolism Pathway Alternations to Immunotherapy. Front Genet 2021;12:646362. [PMID: 34335679 DOI: 10.3389/fgene.2021.646362] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
43 Khare T, Bissonnette M, Khare S. CXCL12-CXCR4/CXCR7 Axis in Colorectal Cancer: Therapeutic Target in Preclinical and Clinical Studies. Int J Mol Sci 2021;22:7371. [PMID: 34298991 DOI: 10.3390/ijms22147371] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 15.0] [Reference Citation Analysis]
44 Gu C, Zhang Y, Chen D, Liu H, Mi K. Tunicamycin-induced endoplasmic reticulum stress inhibits chemoresistance of FaDu hypopharyngeal carcinoma cells in 3D collagen I cultures and in vivo. Exp Cell Res 2021;405:112725. [PMID: 34224701 DOI: 10.1016/j.yexcr.2021.112725] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
45 Yan H, Du X, Wang R, Zhai G. Progress in the study of D-α-tocopherol polyethylene glycol 1000 succinate (TPGS) reversing multidrug resistance. Colloids Surf B Biointerfaces 2021;205:111914. [PMID: 34130211 DOI: 10.1016/j.colsurfb.2021.111914] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
46 Bae JA, Bae WK, Kim SJ, Ko YS, Kim KY, Park SY, Yu YH, Kim EA, Chung IJ, Kim H, Ha HH, Kim KK. A new KSRP-binding compound suppresses distant metastasis of colorectal cancer by targeting the oncogenic KITENIN complex. Mol Cancer 2021;20:78. [PMID: 34039363 DOI: 10.1186/s12943-021-01368-w] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
47 Ding J, Mao Q, Zhao M, Gao Y, Wang A, Ye S, Wang X, Xie W, Shi H. Protein sulfenic acid-mediated anchoring of gold nanoparticles for enhanced CT imaging and radiotherapy of tumors in vivo. Nanoscale 2020;12:22963-9. [PMID: 33206090 DOI: 10.1039/d0nr06440h] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
48 Chen J, Wang H, Jia L, He J, Li Y, Liu H, Wu R, Qiu Y, Zhan Y, Yuan Z, Cao Y, Li W, Xu K, Yin P. Bufalin targets the SRC-3/MIF pathway in chemoresistant cells to regulate M2 macrophage polarization in colorectal cancer. Cancer Lett 2021;513:63-74. [PMID: 34000344 DOI: 10.1016/j.canlet.2021.05.008] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
49 Simioni C, Conti I, Varano G, Brenna C, Costanzi E, Neri LM. The Complexity of the Tumor Microenvironment and Its Role in Acute Lymphoblastic Leukemia: Implications for Therapies. Front Oncol 2021;11:673506. [PMID: 34026651 DOI: 10.3389/fonc.2021.673506] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
50 Cheng KC, Chen CF, Hung CC, Lam SH, Hung HY, Li YC, Chen FA, Shieh PC, Kuo PC, Wu TS. Bioactive naphthoquinones and triterpenoids from the fruiting bodies of Taiwanofungus salmoneus. Bioorg Chem 2021;112:104939. [PMID: 33951534 DOI: 10.1016/j.bioorg.2021.104939] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
51 Krishnan SM, Laarif SS, Bender BC, Quartino AL, Friberg LE. Tumor growth inhibition modeling of individual lesion dynamics and interorgan variability in HER2-negative breast cancer patients treated with docetaxel. CPT Pharmacometrics Syst Pharmacol 2021;10:511-21. [PMID: 33818899 DOI: 10.1002/psp4.12629] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
52 Du C, Li S, Li Y, Galons H, Guo N, Teng Y, Zhang Y, Li M, Yu P. F7 and topotecan co-loaded thermosensitive liposome as a nano-drug delivery system for tumor hyperthermia. Drug Deliv 2020;27:836-47. [PMID: 32508162 DOI: 10.1080/10717544.2020.1772409] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
53 Miserocchi G, Cocchi C, De Vita A, Liverani C, Spadazzi C, Calpona S, Di Menna G, Bassi M, Meccariello G, De Luca G, Campobassi A, Maddalena Tumedei M, Bongiovanni A, Fausti V, Cotelli F, Ibrahim T, Mercatali L. Three-dimensional collagen-based scaffold model to study the microenvironment and drug-resistance mechanisms of oropharyngeal squamous cell carcinomas. Cancer Biol Med 2021:j. [PMID: 33772505 DOI: 10.20892/j.issn.2095-3941.2020.0482] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
54 Wang X, Zhong L, Zhao Y. Oncolytic adenovirus: A tool for reversing the tumor microenvironment and promoting cancer treatment (Review). Oncol Rep 2021;45:49. [PMID: 33760203 DOI: 10.3892/or.2021.8000] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
55 Meng S, Alanazi R, Ji D, Bandura J, Luo ZW, Fleig A, Feng ZP, Sun HS. Role of TRPM7 kinase in cancer. Cell Calcium 2021;96:102400. [PMID: 33784560 DOI: 10.1016/j.ceca.2021.102400] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
56 Peixoto da Silva S, Caires HR, Bergantim R, Guimarães JE, Vasconcelos MH. miRNAs mediated drug resistance in hematological malignancies. Semin Cancer Biol 2021:S1044-579X(21)00064-X. [PMID: 33757848 DOI: 10.1016/j.semcancer.2021.03.014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
57 Patel JP, Spiller SE, Barker ED. Drug penetration in pediatric brain tumors: Challenges and opportunities. Pediatr Blood Cancer 2021;68:e28983. [PMID: 33719183 DOI: 10.1002/pbc.28983] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
58 Chen RL, Wang Z, Huang P, Sun CH, Yu WY, Zhang HH, Yu CH, He JQ. Isovitexin potentiated the antitumor activity of cisplatin by inhibiting the glucose metabolism of lung cancer cells and reduced cisplatin-induced immunotoxicity in mice. Int Immunopharmacol 2021;94:107357. [PMID: 33715980 DOI: 10.1016/j.intimp.2020.107357] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
59 Kurter H, Yeşil J, Daskin E, Çalibaşi Koçal G, Ellidokuz H, Başbinar Y. Drug Resistance Mechanisms on Colorectal Cancer. Journal of Basic and Clinical Health Sciences 2021;5:88-93. [DOI: 10.30621/jbachs.869310] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
60 Wu P, Gao W, Su M, Nice EC, Zhang W, Lin J, Xie N. Adaptive Mechanisms of Tumor Therapy Resistance Driven by Tumor Microenvironment. Front Cell Dev Biol 2021;9:641469. [PMID: 33732706 DOI: 10.3389/fcell.2021.641469] [Cited by in Crossref: 14] [Cited by in F6Publishing: 36] [Article Influence: 14.0] [Reference Citation Analysis]
61 Clerici SP, Oliveira PFS, Akagi EM, Cordeiro HG, Azevedo-Martins JM, Faria AVS, Ferreira-Halder CV. A comprehensive review on the role of protein tyrosine phosphatases in gastric cancer development and progression. Biol Chem 2021;402:663-74. [PMID: 33544466 DOI: 10.1515/hsz-2020-0355] [Reference Citation Analysis]
62 Ma S, McGuire MH, Mangala LS, Lee S, Stur E, Hu W, Bayraktar E, Villar-Prados A, Ivan C, Wu SY, Yokoi A, Dasari SK, Jennings NB, Liu J, Lopez-Berestein G, Ram P, Sood AK. Gain-of-function p53 protein transferred via small extracellular vesicles promotes conversion of fibroblasts to a cancer-associated phenotype. Cell Rep 2021;34:108726. [PMID: 33567287 DOI: 10.1016/j.celrep.2021.108726] [Cited by in Crossref: 3] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
63 Wei X, Shi Y, Dai Z, Wang P, Meng X, Yin B. Underlying metastasis mechanism and clinical application of exosomal circular RNA in tumors (Review). Int J Oncol 2021;58:289-97. [PMID: 33650643 DOI: 10.3892/ijo.2021.5179] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
64 Kinoshita T, Goto T. Links between Inflammation and Postoperative Cancer Recurrence. J Clin Med 2021;10:E228. [PMID: 33435255 DOI: 10.3390/jcm10020228] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
65 Ren Y, Kinghorn AD. Antitumor potential of the protein phosphatase inhibitor, cantharidin, and selected derivatives. Bioorg Med Chem 2021;32:116012. [PMID: 33454654 DOI: 10.1016/j.bmc.2021.116012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
66 Roy T, Boateng ST, Banang-Mbeumi S, Singh PK, Basnet P, Chamcheu RN, Ladu F, Chauvin I, Spiegelman VS, Hill RA, Kousoulas KG, Nagalo BM, Walker AL, Fotie J, Murru S, Sechi M, Chamcheu JC. Synthesis, inverse docking-assisted identification and in vitro biological characterization of Flavonol-based analogs of fisetin as c-Kit, CDK2 and mTOR inhibitors against melanoma and non-melanoma skin cancers. Bioorg Chem 2021;107:104595. [PMID: 33450548 DOI: 10.1016/j.bioorg.2020.104595] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
67 Zhu GX, Gao D, Shao ZZ, Chen L, Ding WJ, Yu QF. Wnt/β‑catenin signaling: Causes and treatment targets of drug resistance in colorectal cancer (Review). Mol Med Rep 2021;23:105. [PMID: 33300082 DOI: 10.3892/mmr.2020.11744] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
68 Li L, Huang S, Yao Y, Chen J, Li J, Xiang X, Deng J, Xiong J. Follistatin-like 1 (FSTL1) is a prognostic biomarker and correlated with immune cell infiltration in gastric cancer. World J Surg Oncol 2020;18:324. [PMID: 33292276 DOI: 10.1186/s12957-020-02070-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
69 Li B, Jiang J, Assaraf YG, Xiao H, Chen Z, Huang C. Surmounting cancer drug resistance: New insights from the perspective of N6-methyladenosine RNA modification. Drug Resistance Updates 2020;53:100720. [DOI: 10.1016/j.drup.2020.100720] [Cited by in Crossref: 19] [Cited by in F6Publishing: 51] [Article Influence: 9.5] [Reference Citation Analysis]
70 Dominijanni A, Devarasetty M, Soker S. Manipulating the Tumor Microenvironment in Tumor Organoids Induces Phenotypic Changes and Chemoresistance. iScience 2020;23:101851. [PMID: 33319176 DOI: 10.1016/j.isci.2020.101851] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
71 Hijaze N, Ledersnaider M, Simanovich E, Kassem S, Rahat MA. Inducing regulated necrosis and shifting macrophage polarization with anti-EMMPRIN antibody (161-pAb) and complement factors. J Leukoc Biol 2021;110:343-56. [PMID: 33205451 DOI: 10.1002/JLB.3A0520-333R] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
72 Gong Y, Deng J, Wu X. Germline mutations and blood malignancy (Review). Oncol Rep 2021;45:49-57. [PMID: 33200226 DOI: 10.3892/or.2020.7846] [Reference Citation Analysis]
73 Yang G, Shi R, Zhang Q. Hypoxia and Oxygen-Sensing Signaling in Gene Regulation and Cancer Progression. Int J Mol Sci 2020;21:E8162. [PMID: 33142830 DOI: 10.3390/ijms21218162] [Cited by in Crossref: 5] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
74 Zhao P, Zhang J, Wu A, Zhang M, Zhao Y, Tang Y, Wang B, Chen T, Li F, Zhao Q, Huang Y. Biomimetic codelivery overcomes osimertinib-resistant NSCLC and brain metastasis via macrophage-mediated innate immunity. J Control Release 2021;329:1249-61. [PMID: 33129919 DOI: 10.1016/j.jconrel.2020.10.052] [Cited by in Crossref: 7] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
75 Dong X, Sun R, Wang J, Yu S, Cui J, Guo Z, Pan X, Sun J, Yang J, Pan LL. Glutathione S-transferases P1-mediated interleukin-6 in tumor-associated macrophages augments drug-resistance in MCF-7 breast cancer. Biochem Pharmacol 2020;182:114289. [PMID: 33080187 DOI: 10.1016/j.bcp.2020.114289] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
76 Jia M, Li Z, Pan M, Tao M, Lu X, Liu Y. Evaluation of immune infiltrating of thyroid cancer based on the intrinsic correlation between pair-wise immune genes. Life Sci 2020;259:118248. [PMID: 32791153 DOI: 10.1016/j.lfs.2020.118248] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
77 Sun R, Luo H, Su J, Di S, Zhou M, Shi B, Sun Y, Du G, Zhang H, Jiang H, Li Z. Olaparib Suppresses MDSC Recruitment via SDF1α/CXCR4 Axis to Improve the Anti-tumor Efficacy of CAR-T Cells on Breast Cancer in Mice. Mol Ther 2021;29:60-74. [PMID: 33010818 DOI: 10.1016/j.ymthe.2020.09.034] [Cited by in Crossref: 3] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
78 Zhai Z, Samson JM, Yamauchi T, Vaddi PK, Matsumoto Y, Dinarello CA, Ravindran Menon D, Fujita M. Inflammasome Sensor NLRP1 Confers Acquired Drug Resistance to Temozolomide in Human Melanoma. Cancers (Basel) 2020;12:E2518. [PMID: 32899791 DOI: 10.3390/cancers12092518] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
79 Akbarzadeh M, Akbarzadeh S, Majidinia M. Targeting Notch signaling pathway as an effective strategy in overcoming drug resistance in ovarian cancer. Pathol Res Pract 2020;216:153158. [PMID: 32829107 DOI: 10.1016/j.prp.2020.153158] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
80 Yao K, Wei L, Zhang J, Wang C, Wang C, Qin C, Li S. Prognostic values of GPNMB identified by mining TCGA database and STAD microenvironment. Aging (Albany NY) 2020;12:16238-54. [PMID: 32833670 DOI: 10.18632/aging.103646] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
81 Dong Z, Hao Y, Li Q, Yang Z, Zhu Y, Liu Z, Feng L. Metal-polyphenol-network coated CaCO3 as pH-responsive nanocarriers to enable effective intratumoral penetration and reversal of multidrug resistance for augmented cancer treatments. Nano Res 2020;13:3057-67. [DOI: 10.1007/s12274-020-2972-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
82 Zhao MF, Liang GD, Zhou YJ, Chi ZP, Zhuang H, Zhu SL, Wang Y, Liu GR, Zhao JB, Liu SL. Novel Bacillus strains from the human gut exert anticancer effects on a broad range of malignancy types. Invest New Drugs 2020;38:1373-82. [PMID: 32734371 DOI: 10.1007/s10637-020-00906-5] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
83 Haider T, Pandey V, Banjare N, Gupta PN, Soni V. Drug resistance in cancer: mechanisms and tackling strategies. Pharmacol Rep 2020;72:1125-51. [PMID: 32700248 DOI: 10.1007/s43440-020-00138-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 30] [Article Influence: 3.5] [Reference Citation Analysis]
84 Gronseth E, Gupta A, Koceja C, Kumar S, Kutty RG, Rarick K, Wang L, Ramchandran R. Astrocytes influence medulloblastoma phenotypes and CD133 surface expression. PLoS One 2020;15:e0235852. [PMID: 32628717 DOI: 10.1371/journal.pone.0235852] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
85 Fernandes S, Cassani M, Pagliari S, Filipensky P, Cavalieri F, Forte G. Tumor in 3D: In Vitro Complex Cellular Models to Improve Nanodrugs Cancer Therapy. Curr Med Chem 2020;27:7234-55. [PMID: 32586245 DOI: 10.2174/0929867327666200625151134] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
86 Sanegre S, Lucantoni F, Burgos-Panadero R, de La Cruz-Merino L, Noguera R, Álvaro Naranjo T. Integrating the Tumor Microenvironment into Cancer Therapy. Cancers (Basel) 2020;12:E1677. [PMID: 32599891 DOI: 10.3390/cancers12061677] [Cited by in Crossref: 7] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
87 Yoo SY, Badrinath N, Jeong SN, Woo HY, Heo J. Overcoming Tumor Resistance to Oncolyticvaccinia Virus with Anti-PD-1-Based Combination Therapy by Inducing Antitumor Immunity in the Tumor Microenvironment. Vaccines (Basel) 2020;8:E321. [PMID: 32575351 DOI: 10.3390/vaccines8020321] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
88 Song Y, Xu M, Li Y, Li Y, Gu W, Halimu G, Fu X, Zhang H, Zhang C. An iRGD peptide fused superantigen mutant induced tumor-targeting and T lymphocyte infiltrating in cancer immunotherapy. Int J Pharm 2020;586:119498. [PMID: 32505575 DOI: 10.1016/j.ijpharm.2020.119498] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
89 Wang H, Huang Y. Combination therapy based on nano codelivery for overcoming cancer drug resistance. Medicine in Drug Discovery 2020;6:100024. [DOI: 10.1016/j.medidd.2020.100024] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 5.5] [Reference Citation Analysis]
90 Gumusay O, Vitiello PP, Wabl C, Corcoran RB, Bardelli A, Rugo HS. Strategic Combinations to Prevent and Overcome Resistance to Targeted Therapies in Oncology. Am Soc Clin Oncol Educ Book 2020;40:e292-308. [PMID: 32453634 DOI: 10.1200/EDBK_280845] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
91 Lepeltier E, Rijo P, Rizzolio F, Popovtzer R, Petrikaite V, Assaraf YG, Passirani C. Nanomedicine to target multidrug resistant tumors. Drug Resist Updat 2020;52:100704. [PMID: 32512316 DOI: 10.1016/j.drup.2020.100704] [Cited by in Crossref: 22] [Cited by in F6Publishing: 47] [Article Influence: 11.0] [Reference Citation Analysis]
92 Pérez-Velázquez J, Rejniak KA. Drug-Induced Resistance in Micrometastases: Analysis of Spatio-Temporal Cell Lineages. Front Physiol 2020;11:319. [PMID: 32362836 DOI: 10.3389/fphys.2020.00319] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
93 Wang C, Xu J, Yuan D, Bai Y, Pan Y, Zhang J, Shao C. Exosomes carrying ALDOA and ALDH3A1 from irradiated lung cancer cells enhance migration and invasion of recipients by accelerating glycolysis. Mol Cell Biochem 2020;469:77-87. [PMID: 32297178 DOI: 10.1007/s11010-020-03729-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
94 Witzke K, Seebauer C, Jesse K, Kwiatek E, Berner J, Semmler M, Boeckmann L, Emmert S, Weltmann K, Metelmann H, Bekeschus S. Plasma medical oncology: Immunological interpretation of head and neck squamous cell carcinoma. Plasma Process Polym 2020;17:1900258. [DOI: 10.1002/ppap.201900258] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
95 Bogusławska-Duch J, Ducher M, Małecki M. Resistance of melanoma cells to anticancer treatment: a role of vascular endothelial growth factor. Postepy Dermatol Alergol 2020;37:11-8. [PMID: 32467677 DOI: 10.5114/ada.2020.93378] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
96 Deng Z, Wu J, Xu S, Chen F, Zhang Z, Jin A, Wang J. Exosomes-microRNAs interacted with gastric cancer and its microenvironment: a mini literature review. Biomark Med 2020;14:141-50. [PMID: 32064893 DOI: 10.2217/bmm-2019-0387] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
97 Li G, Zhao L. Sorafenib-loaded hydroxyethyl starch-TG100-115 micelles for the treatment of liver cancer based on synergistic treatment. Drug Deliv 2019;26:756-64. [PMID: 31357893 DOI: 10.1080/10717544.2019.1642418] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
98 Yao M, Ventura PB, Jiang Y, Rodriguez FJ, Wang L, Perry JSA, Yang Y, Wahl K, Crittenden RB, Bennett ML, Qi L, Gong CC, Li XN, Barres BA, Bender TP, Ravichandran KS, Janes KA, Eberhart CG, Zong H. Astrocytic trans-Differentiation Completes a Multicellular Paracrine Feedback Loop Required for Medulloblastoma Tumor Growth. Cell 2020;180:502-520.e19. [PMID: 31983537 DOI: 10.1016/j.cell.2019.12.024] [Cited by in Crossref: 28] [Cited by in F6Publishing: 44] [Article Influence: 14.0] [Reference Citation Analysis]
99 Costea T, Vlad OC, Miclea LC, Ganea C, Szöllősi J, Mocanu MM. Alleviation of Multidrug Resistance by Flavonoid and Non-Flavonoid Compounds in Breast, Lung, Colorectal and Prostate Cancer. Int J Mol Sci 2020;21:E401. [PMID: 31936346 DOI: 10.3390/ijms21020401] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 14.5] [Reference Citation Analysis]
100 Zargar A, Chang S, Kothari A, Snijders AM, Mao JH, Wang J, Hernández AC, Keasling JD, Bivona TG. Overcoming the challenges of cancer drug resistance through bacterial-mediated therapy. Chronic Dis Transl Med 2019;5:258-66. [PMID: 32055785 DOI: 10.1016/j.cdtm.2019.11.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
101 Meng X, Xu Y, Lu Q, Sun L, An X, Zhang J, Chen J, Gao Y, Zhang Y, Ning X. Ultrasound-responsive alkaline nanorobots for the treatment of lactic acidosis-mediated doxorubicin resistance. Nanoscale 2020;12:13801-10. [DOI: 10.1039/d0nr03726e] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
102 Wu H, Liu L, Song L, Ma M, Gu N, Zhang Y. Enhanced Tumor Synergistic Therapy by Injectable Magnetic Hydrogel Mediated Generation of Hyperthermia and Highly Toxic Reactive Oxygen Species. ACS Nano 2019;13:14013-23. [PMID: 31639298 DOI: 10.1021/acsnano.9b06134] [Cited by in Crossref: 80] [Cited by in F6Publishing: 77] [Article Influence: 26.7] [Reference Citation Analysis]
103 Fan JH, Fan GL, Yuan P, Deng FA, Liu LS, Zhou X, Yu XY, Cheng H, Li SY. A Theranostic Nanoprobe for Hypoxia Imaging and Photodynamic Tumor Therapy. Front Chem 2019;7:868. [PMID: 31921785 DOI: 10.3389/fchem.2019.00868] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
104 Heudobler D, Lüke F, Vogelhuber M, Klobuch S, Pukrop T, Herr W, Gerner C, Pantziarka P, Ghibelli L, Reichle A. Anakoinosis: Correcting Aberrant Homeostasis of Cancer Tissue-Going Beyond Apoptosis Induction. Front Oncol 2019;9:1408. [PMID: 31921665 DOI: 10.3389/fonc.2019.01408] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
105 Giopanou I, Pintzas A. RAS and BRAF in the foreground for non-small cell lung cancer and colorectal cancer: Similarities and main differences for prognosis and therapies. Crit Rev Oncol Hematol 2020;146:102859. [PMID: 31927392 DOI: 10.1016/j.critrevonc.2019.102859] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
106 Zhong X, Zhang Y, Wang L, Zhang H, Liu H, Liu Y. Cellular components in tumor microenvironment of neuroblastoma and the prognostic value. PeerJ 2019;7:e8017. [PMID: 31844563 DOI: 10.7717/peerj.8017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
107 Chen M, Xu G, Fan M, Jia H, Xiao L, Lang J. Anti-tumour effects of a xenogeneic fibroblast activation protein-based whole cell tumour vaccine in murine tumour models. Artif Cells Nanomed Biotechnol 2019;47:4182-93. [PMID: 31722575 DOI: 10.1080/21691401.2019.1687498] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
108 Jing X, Yang F, Shao C, Wei K, Xie M, Shen H, Shu Y. Role of hypoxia in cancer therapy by regulating the tumor microenvironment. Mol Cancer. 2019;18:157. [PMID: 31711497 DOI: 10.1186/s12943-019-1089-9] [Cited by in Crossref: 221] [Cited by in F6Publishing: 457] [Article Influence: 73.7] [Reference Citation Analysis]
109 Zhang W, Zhang W, Sun L, Xiang L, Lai X, Li Q, Sun S. The effects and mechanisms of epigallocatechin-3-gallate on reversing multidrug resistance in cancer. Trends in Food Science & Technology 2019;93:221-33. [DOI: 10.1016/j.tifs.2019.09.017] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
110 Dang N, Waer M, Sprangers B, Lin Y. Improved Anti-Tumour Adaptive Immunity Can Overcome the Melanoma Immunosuppressive Tumour Microenvironment. Cancers (Basel) 2019;11:E1694. [PMID: 31683642 DOI: 10.3390/cancers11111694] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
111 Nogueira A, Fernandes M, Catarino R, Medeiros R. RAD52 Functions in Homologous Recombination and Its Importance on Genomic Integrity Maintenance and Cancer Therapy. Cancers (Basel) 2019;11:E1622. [PMID: 31652722 DOI: 10.3390/cancers11111622] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 6.7] [Reference Citation Analysis]
112 Hung HY, Hung CC, Liang JW, Chen CF, Chen HY, Shieh PC, Kuo PC, Wu TS. Constituents and Anti-Multidrug Resistance Activity of Taiwanofungus camphoratus on Human Cervical Cancer Cells. Molecules 2019;24:E3730. [PMID: 31623176 DOI: 10.3390/molecules24203730] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
113 Gao L, Dou ZC, Ren WH, Li SM, Liang X, Zhi KQ. CircCDR1as upregulates autophagy under hypoxia to promote tumor cell survival via AKT/ERK½/mTOR signaling pathways in oral squamous cell carcinomas. Cell Death Dis 2019;10:745. [PMID: 31582727 DOI: 10.1038/s41419-019-1971-9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 38] [Article Influence: 6.7] [Reference Citation Analysis]
114 Sun CH, Li BB, Wang B, Zhao J, Zhang XY, Li TT, Li WB, Tang D, Qiu MJ, Wang XC, Zhu CM, Qian ZR. The role of Fusobacterium nucleatum in colorectal cancer: from carcinogenesis to clinical management. Chronic Dis Transl Med 2019;5:178-87. [PMID: 31891129 DOI: 10.1016/j.cdtm.2019.09.001] [Cited by in Crossref: 23] [Cited by in F6Publishing: 38] [Article Influence: 7.7] [Reference Citation Analysis]
115 Deshmukh SK, Srivastava SK, Poosarla T, Dyess DL, Holliday NP, Singh AP, Singh S. Inflammation, immunosuppressive microenvironment and breast cancer: opportunities for cancer prevention and therapy. Ann Transl Med 2019;7:593. [PMID: 31807574 DOI: 10.21037/atm.2019.09.68] [Cited by in Crossref: 13] [Cited by in F6Publishing: 25] [Article Influence: 4.3] [Reference Citation Analysis]
116 Liverani C, De Vita A, Minardi S, Kang Y, Mercatali L, Amadori D, Bongiovanni A, La Manna F, Ibrahim T, Tasciotti E. A biomimetic 3D model of hypoxia-driven cancer progression. Sci Rep 2019;9:12263. [PMID: 31439905 DOI: 10.1038/s41598-019-48701-4] [Cited by in Crossref: 26] [Cited by in F6Publishing: 36] [Article Influence: 8.7] [Reference Citation Analysis]
117 Li F, Guo H, Yang Y, Feng M, Liu B, Ren X, Zhou H. Autophagy modulation in bladder cancer development and treatment (Review). Oncol Rep 2019;42:1647-55. [PMID: 31436298 DOI: 10.3892/or.2019.7286] [Cited by in Crossref: 6] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
118 Aleksakhina SN, Kashyap A, Imyanitov EN. Mechanisms of acquired tumor drug resistance. Biochim Biophys Acta Rev Cancer. 2019;1872:188310. [PMID: 31442474 DOI: 10.1016/j.bbcan.2019.188310] [Cited by in Crossref: 39] [Cited by in F6Publishing: 68] [Article Influence: 13.0] [Reference Citation Analysis]
119 Snezhkina AV, Kudryavtseva AV, Kardymon OL, Savvateeva MV, Melnikova NV, Krasnov GS, Dmitriev AA. ROS Generation and Antioxidant Defense Systems in Normal and Malignant Cells. Oxid Med Cell Longev 2019;2019:6175804. [PMID: 31467634 DOI: 10.1155/2019/6175804] [Cited by in Crossref: 132] [Cited by in F6Publishing: 209] [Article Influence: 44.0] [Reference Citation Analysis]
120 Hua X, Sun Y, Chen J, Wu Y, Sha J, Han S, Zhu X. Circular RNAs in drug resistant tumors. Biomed Pharmacother 2019;118:109233. [PMID: 31351436 DOI: 10.1016/j.biopha.2019.109233] [Cited by in Crossref: 27] [Cited by in F6Publishing: 42] [Article Influence: 9.0] [Reference Citation Analysis]
121 Tsolou A, Lamprou I, Fortosi AO, Liousia M, Giatromanolaki A, Koukourakis MI. 'Stemness' and 'senescence' related escape pathways are dose dependent in lung cancer cells surviving post irradiation. Life Sci 2019;232:116562. [PMID: 31201845 DOI: 10.1016/j.lfs.2019.116562] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
122 Snow O, Lallous N, Singh K, Lack N, Rennie P, Cherkasov A. Androgen receptor plasticity and its implications for prostate cancer therapy. Cancer Treat Rev 2019;81:101871. [PMID: 31698174 DOI: 10.1016/j.ctrv.2019.05.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 26] [Article Influence: 4.7] [Reference Citation Analysis]
123 Piasecka D, Braun M, Kitowska K, Mieczkowski K, Kordek R, Sadej R, Romanska H. FGFs/FGFRs-dependent signalling in regulation of steroid hormone receptors - implications for therapy of luminal breast cancer. J Exp Clin Cancer Res 2019;38:230. [PMID: 31142340 DOI: 10.1186/s13046-019-1236-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
124 Le QV, Suh J, Oh YK. Nanomaterial-Based Modulation of Tumor Microenvironments for Enhancing Chemo/Immunotherapy. AAPS J 2019;21:64. [PMID: 31102154 DOI: 10.1208/s12248-019-0333-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
125 Sakhawat A, Ma L, Muhammad T, Khan AA, Chen X, Huang Y. A tumor targeting oncolytic adenovirus can improve therapeutic outcomes in chemotherapy resistant metastatic human breast carcinoma. Sci Rep 2019;9:7504. [PMID: 31097752 DOI: 10.1038/s41598-019-43668-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
126 Myers KV, Amend SR, Pienta KJ. Targeting Tyro3, Axl and MerTK (TAM receptors): implications for macrophages in the tumor microenvironment. Mol Cancer 2019;18:94. [PMID: 31088471 DOI: 10.1186/s12943-019-1022-2] [Cited by in Crossref: 74] [Cited by in F6Publishing: 117] [Article Influence: 24.7] [Reference Citation Analysis]
127 Bazzichetto C, Conciatori F, Falcone I, Cognetti F, Milella M, Ciuffreda L. Advances in Tumor-Stroma Interactions: Emerging Role of Cytokine Network in Colorectal and Pancreatic Cancer. J Oncol 2019;2019:5373580. [PMID: 31191652 DOI: 10.1155/2019/5373580] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
128 Wang Y, Xu F, Zhang P, Wang P, Wei Y, Wu C, Cheng S. MicroRNA-575 regulates development of gastric cancer by targeting PTEN. Biomedicine & Pharmacotherapy 2019;113:108716. [DOI: 10.1016/j.biopha.2019.108716] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 5.7] [Reference Citation Analysis]
129 Qu Y, Dou B, Tan H, Feng Y, Wang N, Wang D. Tumor microenvironment-driven non-cell-autonomous resistance to antineoplastic treatment. Mol Cancer 2019;18:69. [PMID: 30927928 DOI: 10.1186/s12943-019-0992-4] [Cited by in Crossref: 34] [Cited by in F6Publishing: 45] [Article Influence: 11.3] [Reference Citation Analysis]
130 Izumi D, Toden S, Ureta E, Ishimoto T, Baba H, Goel A. TIAM1 promotes chemoresistance and tumor invasiveness in colorectal cancer. Cell Death Dis 2019;10:267. [PMID: 30890693 DOI: 10.1038/s41419-019-1493-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 33] [Article Influence: 8.0] [Reference Citation Analysis]
131 Ketteler J, Panic A, Reis H, Wittka A, Maier P, Herskind C, Yagüe E, Jendrossek V, Klein D. Progression-Related Loss of Stromal Caveolin 1 Levels Mediates Radiation Resistance in Prostate Carcinoma via the Apoptosis Inhibitor TRIAP1. J Clin Med 2019;8:E348. [PMID: 30871022 DOI: 10.3390/jcm8030348] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
132 Zonneveld MI, Keulers TGH, Rouschop KMA. Extracellular Vesicles as Transmitters of Hypoxia Tolerance in Solid Cancers. Cancers (Basel) 2019;11:E154. [PMID: 30699970 DOI: 10.3390/cancers11020154] [Cited by in Crossref: 24] [Cited by in F6Publishing: 30] [Article Influence: 8.0] [Reference Citation Analysis]
133 Liu W, Wang Q, Chang J. Global metabolomic profiling of trastuzumab resistant gastric cancer cells reveals major metabolic pathways and metabolic signatures based on UHPLC-Q exactive-MS/MS. RSC Adv 2019;9:41192-208. [DOI: 10.1039/c9ra06607a] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
134 Koh B, Jeon H, Kim D, Kang D, Kim KR. Effect of fibroblast co-culture on the proliferation, viability and drug response of colon cancer cells. Oncol Lett 2019;17:2409-17. [PMID: 30675306 DOI: 10.3892/ol.2018.9836] [Cited by in Crossref: 10] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
135 Alharbi M, Zuñiga F, Elfeky O, Guanzon D, Lai A, Rice GE, Perrin L, Hooper J, Salomon C. The potential role of miRNAs and exosomes in chemotherapy in ovarian cancer. Endocrine-Related Cancer 2018;25:R663-85. [DOI: 10.1530/erc-18-0019] [Cited by in Crossref: 23] [Cited by in F6Publishing: 36] [Article Influence: 5.8] [Reference Citation Analysis]
136 Karsch-Bluman A, Feiglin A, Arbib E, Stern T, Shoval H, Schwob O, Berger M, Benny O. Tissue necrosis and its role in cancer progression. Oncogene 2019;38:1920-35. [PMID: 30390074 DOI: 10.1038/s41388-018-0555-y] [Cited by in Crossref: 31] [Cited by in F6Publishing: 38] [Article Influence: 7.8] [Reference Citation Analysis]
137 Nunes AS, Barros AS, Costa EC, Moreira AF, Correia IJ. 3D tumor spheroids as in vitro models to mimic in vivo human solid tumors resistance to therapeutic drugs: NUNES et al.. Biotechnology and Bioengineering 2019;116:206-26. [DOI: 10.1002/bit.26845] [Cited by in Crossref: 196] [Cited by in F6Publishing: 255] [Article Influence: 49.0] [Reference Citation Analysis]
138 Harrison PT, Huang PH. Exploiting vulnerabilities in cancer signalling networks to combat targeted therapy resistance. Essays Biochem 2018;62:583-93. [PMID: 30072489 DOI: 10.1042/EBC20180016] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
139 Zhou Z, Chen J, Yao H, Hu H. Fusobacterium and Colorectal Cancer. Front Oncol. 2018;8:371. [PMID: 30374420 DOI: 10.3389/fonc.2018.00371] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 11.8] [Reference Citation Analysis]
140 Song Y, Tang C, Yin C. Combination antitumor immunotherapy with VEGF and PIGF siRNA via systemic delivery of multi-functionalized nanoparticles to tumor-associated macrophages and breast cancer cells. Biomaterials 2018;185:117-32. [PMID: 30241030 DOI: 10.1016/j.biomaterials.2018.09.017] [Cited by in Crossref: 52] [Cited by in F6Publishing: 70] [Article Influence: 13.0] [Reference Citation Analysis]
141 Baurain JF, Robert C, Mortier L, Neyns B, Grange F, Lebbe C, Ulloa-Montoya F, De Sousa Alves PM, Gillet M, Louahed J, Jarnjak S, Lehmann FF. Association of homogeneous inflamed gene signature with a better outcome in patients with metastatic melanoma treated with MAGE-A3 immunotherapeutic. ESMO Open 2018;3:e000384. [PMID: 30094070 DOI: 10.1136/esmoopen-2018-000384] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
142 Barneh F, Salimi M, Goshadrou F, Ashtiani M, Mirzaie M, Zali H, Jafari M. Valproic acid inhibits the protective effects of stromal cells against chemotherapy in breast cancer: Insights from proteomics and systems biology. J Cell Biochem 2018;119:9270-83. [PMID: 29953653 DOI: 10.1002/jcb.27196] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
143 Bae S, Brumbaugh J, Bonavida B. Exosomes derived from cancerous and non-cancerous cells regulate the anti-tumor response in the tumor microenvironment. Genes Cancer 2018;9:87-100. [PMID: 30108680 DOI: 10.18632/genesandcancer.172] [Cited by in Crossref: 44] [Cited by in F6Publishing: 48] [Article Influence: 11.0] [Reference Citation Analysis]
144 Zhang D, Tang DG, Rycaj K. Cancer stem cells: Regulation programs, immunological properties and immunotherapy. Semin Cancer Biol 2018;52:94-106. [PMID: 29752993 DOI: 10.1016/j.semcancer.2018.05.001] [Cited by in Crossref: 45] [Cited by in F6Publishing: 56] [Article Influence: 11.3] [Reference Citation Analysis]
145 de Assis LVM, Moraes MN, Magalhães-Marques KK, Kinker GS, da Silveira Cruz-Machado S, Castrucci AML. Non-Metastatic Cutaneous Melanoma Induces Chronodisruption in Central and Peripheral Circadian Clocks. Int J Mol Sci 2018;19:E1065. [PMID: 29614021 DOI: 10.3390/ijms19041065] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
146 Ketteler J, Klein D. Caveolin-1, cancer and therapy resistance. Int J Cancer 2018;143:2092-104. [PMID: 29524224 DOI: 10.1002/ijc.31369] [Cited by in Crossref: 45] [Cited by in F6Publishing: 64] [Article Influence: 11.3] [Reference Citation Analysis]
147 Mahaweni NM, Bos GMJ, Mitsiades CS, Tilanus MGJ, Wieten L. Daratumumab augments alloreactive natural killer cell cytotoxicity towards CD38+ multiple myeloma cell lines in a biochemical context mimicking tumour microenvironment conditions. Cancer Immunol Immunother 2018;67:861-72. [PMID: 29500635 DOI: 10.1007/s00262-018-2140-1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 5.8] [Reference Citation Analysis]
148 Lamprecht S, Sigal-Batikoff I, Shany S, Abu-Freha N, Ling E, Delinasios GJ, Moyal-Atias K, Delinasios JG, Fich A. Teaming Up for Trouble: Cancer Cells, Transforming Growth Factor-β1 Signaling and the Epigenetic Corruption of Stromal Naïve Fibroblasts. Cancers (Basel) 2018;10:E61. [PMID: 29495500 DOI: 10.3390/cancers10030061] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 4.5] [Reference Citation Analysis]
149 Habiel DM, Krepostman N, Lilly M, Cavassani K, Coelho AL, Shibata T, Elenitoba-Johnson K, Hogaboam CM. Senescent stromal cell-induced divergence and therapeutic resistance in T cell acute lymphoblastic leukemia/lymphoma. Oncotarget 2016;7:83514-29. [PMID: 27835864 DOI: 10.18632/oncotarget.13158] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
150 Nanayakkara AK, Follit CA, Chen G, Williams NS, Vogel PD, Wise JG. Targeted inhibitors of P-glycoprotein increase chemotherapeutic-induced mortality of multidrug resistant tumor cells. Sci Rep 2018;8:967. [PMID: 29343829 DOI: 10.1038/s41598-018-19325-x] [Cited by in Crossref: 89] [Cited by in F6Publishing: 124] [Article Influence: 22.3] [Reference Citation Analysis]
151 Bonavida B, Chouaib S. Resistance to anticancer immunity in cancer patients: potential strategies to reverse resistance. Ann Oncol 2017;28:457-67. [PMID: 27864216 DOI: 10.1093/annonc/mdw615] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
152 Chang H, Wei JW, Tao YL, Ding PR, Xia YF, Gao YH, Xiao WW. CCR6 Is a Predicting Biomarker of Radiosensitivity and Potential Target of Radiosensitization in Rectal Cancer. Cancer Res Treat 2018;50:1203-13. [PMID: 29268566 DOI: 10.4143/crt.2017.538] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
153 Katano A, Takahashi W, Yamashita H, Yamamoto K, Ando M, Yoshida M, Saito Y, Abe O, Nakagawa K. The impact of elevated C-reactive protein level on the prognosis for oro-hypopharynx cancer patients treated with radiotherapy. Sci Rep 2017;7:17805. [PMID: 29259311 DOI: 10.1038/s41598-017-18233-w] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
154 Salerno L, Romeo G, Modica MN, Amata E, Sorrenti V, Barbagallo I, Pittalà V. Heme oxygenase-1: A new druggable target in the management of chronic and acute myeloid leukemia. European Journal of Medicinal Chemistry 2017;142:163-78. [DOI: 10.1016/j.ejmech.2017.07.031] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 7.6] [Reference Citation Analysis]
155 Derbal Y. Perspective on the dynamics of cancer. Theor Biol Med Model 2017;14:18. [PMID: 28969664 DOI: 10.1186/s12976-017-0066-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
156 Teow SY, Liew K, Khoo AS, Peh SC. Pathogenic Role of Exosomes in Epstein-Barr Virus (EBV)-Associated Cancers. Int J Biol Sci 2017;13:1276-86. [PMID: 29104494 DOI: 10.7150/ijbs.19531] [Cited by in Crossref: 20] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
157 Zhao J, Jin G, Weng G, Li J, Zhu J, Zhao J. Recent advances in activatable fluorescence imaging probes for tumor imaging. Drug Discovery Today 2017;22:1367-74. [DOI: 10.1016/j.drudis.2017.04.006] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 5.8] [Reference Citation Analysis]
158 Yang F, Ning Z, Ma L, Liu W, Shao C, Shu Y, Shen H. Exosomal miRNAs and miRNA dysregulation in cancer-associated fibroblasts. Mol Cancer 2017;16:148. [PMID: 28851377 DOI: 10.1186/s12943-017-0718-4] [Cited by in Crossref: 85] [Cited by in F6Publishing: 133] [Article Influence: 17.0] [Reference Citation Analysis]
159 Liu P, Ma D, Yu Z, Zhe N, Ren M, Wang P, Yu M, Huang J, Fang Q, Wang J. Overexpression of heme oxygenase-1 in bone marrow stromal cells promotes microenvironment-mediated imatinib resistance in chronic myeloid leukemia. Biomedicine & Pharmacotherapy 2017;91:21-30. [DOI: 10.1016/j.biopha.2017.04.076] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 4.4] [Reference Citation Analysis]
160 Liu H, Jie M, He Z, Li H, Lin J. Study of antioxidant effects on malignant glioma cells by constructing a tumor-microvascular structure on microchip. Analytica Chimica Acta 2017;978:1-9. [DOI: 10.1016/j.aca.2017.05.009] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 3.6] [Reference Citation Analysis]
161 Liu CY, Chen KF, Chao TI, Chu PY, Huang CT, Huang TT, Yang HP, Wang WL, Lee CH, Lau KY, Tsai WC, Su JC, Wu CY, Chen MH, Shiau CW, Tseng LM. Sequential combination of docetaxel with a SHP-1 agonist enhanced suppression of p-STAT3 signaling and apoptosis in triple negative breast cancer cells. J Mol Med (Berl) 2017;95:965-75. [PMID: 28578456 DOI: 10.1007/s00109-017-1549-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
162 Muntimadugu E, Kommineni N, Khan W. Exploring the Potential of Nanotherapeutics in Targeting Tumor Microenvironment for Cancer Therapy. Pharmacol Res 2017;126:109-22. [PMID: 28511988 DOI: 10.1016/j.phrs.2017.05.010] [Cited by in Crossref: 32] [Cited by in F6Publishing: 42] [Article Influence: 6.4] [Reference Citation Analysis]
163 Owusu BY, Galemmo R, Janetka J, Klampfer L. Hepatocyte Growth Factor, a Key Tumor-Promoting Factor in the Tumor Microenvironment. Cancers (Basel). 2017;9. [PMID: 28420162 DOI: 10.3390/cancers9040035] [Cited by in Crossref: 37] [Cited by in F6Publishing: 46] [Article Influence: 7.4] [Reference Citation Analysis]
164 Zhan HX, Zhou B, Cheng YG, Xu JW, Wang L, Zhang GY, Hu SY. Crosstalk between stromal cells and cancer cells in pancreatic cancer: New insights into stromal biology. Cancer Lett. 2017;392:83-93. [PMID: 28189533 DOI: 10.1016/j.canlet.2017.01.041] [Cited by in Crossref: 53] [Cited by in F6Publishing: 70] [Article Influence: 10.6] [Reference Citation Analysis]
165 Panic A, Ketteler J, Reis H, Sak A, Herskind C, Maier P, Rübben H, Jendrossek V, Klein D. Progression-related loss of stromal Caveolin 1 levels fosters the growth of human PC3 xenografts and mediates radiation resistance. Sci Rep 2017;7:41138. [PMID: 28112237 DOI: 10.1038/srep41138] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]
166 Tashireva LA, Denisov EV, Gerashchenko TS, Pautova DN, Buldakov MA, Zavyalova MV, Kzhyshkowska J, Cherdyntseva NV, Perelmuter VM. Intratumoral heterogeneity of macrophages and fibroblasts in breast cancer is associated with the morphological diversity of tumor cells and contributes to lymph node metastasis. Immunobiology 2017;222:631-40. [PMID: 27916281 DOI: 10.1016/j.imbio.2016.11.012] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
167 Rampias T, Favicchio R, Stebbing J, Giamas G. Targeting tumor–stroma crosstalk: the example of the NT157 inhibitor. Oncogene 2016;35:2562-4. [DOI: 10.1038/onc.2015.392] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]